BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/29/2025 6:52:41 AM | Browse: 777 | Download: 14
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Antibiotic consumption of inpatients with inflammatory bowel disease during 2015-2024 and future prediction: Evidence from a general hospital
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wen Zeng, Wei-Kun Zhang, Duo Xu, Kun He, Yu-Ping Huang, Yu-Xi Liu and Hui-Fang Yang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Hunan Province |
No. 2024JJ7477 |
| Shaoyang Science and Technology Plan Project |
No. 2024GZ2025 |
|
| Corresponding Author |
Hui-Fang Yang, MD, College of Public Health, Ningxia Medical University, No. 1160 Victory Street, Yinchuan 750004, Ningxia Hui Autonomous Region, China. joyceyhf@163.com |
| Key Words |
Inflammatory bowel disease; Inpatients; Ulcerative colitis; Crohn’s disease; Antibiotic consumption; Monte Carlo simulation |
| Core Tip |
This retrospective study analyzed antibiotic consumption of hospitalized Inflammatory bowel disease patients and predicted future trends. Among hospitalized patients, the usage of antibiotics was higher in elderly patients, male patients, and those with ulcerative colitis. The study also found that although the overall usage rate has declined in recent years, the use of “last-resort” antibiotics has significantly increased. The Monte Carlo simulation predicts that antibiotic consumption will double by 2027. These findings indicate an urgent need for targeted antimicrobial management. |
| Citation |
Zeng W, Zhang WK, Xu D, He K, Huang YP, Liu YX, Yang HF. Antibiotic consumption of inpatients with inflammatory bowel disease during 2015-2024 and future prediction: Evidence from a general hospital. World J Gastroenterol 2025; In press |
 |
Received |
|
2025-10-11 16:29 |
 |
Peer-Review Started |
|
2025-10-11 16:29 |
 |
First Decision by Editorial Office Director |
|
2025-11-11 09:47 |
 |
Return for Revision |
|
2025-11-11 09:47 |
 |
Revised |
|
2025-11-21 12:24 |
 |
Publication Fee Transferred |
|
2025-11-28 14:53 |
 |
Second Decision by Editor |
|
2025-12-29 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-29 06:52 |
 |
Articles in Press |
|
2025-12-29 06:52 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345